ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,578Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 17

$1.34M Total Retail Price of All Prescriptions

Rank: 4 out of 17

468 Patients Receiving at Least One Drug in Part D
82% Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Missouri
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

22% of this provider’s 468 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

27% of this provider’s 468 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 35.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LEVOTHYROXINE SODIUM 955 861 119 1 1
HYDROCODONE-ACETAMINOPHEN 783 732 125 S3 2 4
FUROSEMIDE 708 654 99 3 3
POTASSIUM CHLORIDE 671 615 91 4 6
LISINOPRIL 553 474 90 5 2
GABAPENTIN 467 406 67 6 10
AMLODIPINE BESYLATE 456 419 71 7 8
NAMENDA 432 432 45 8 5
CITALOPRAM HBR 412 388 65 9 18
LANTUS 379 322 39 10 27
METOPROLOL TARTRATE 355 328 46 11 11
DONEPEZIL HCL 353 353 54 12 13
OMEPRAZOLE 345 288 54 13 9
RANITIDINE HCL 318 290 44 14 23
TRAMADOL HCL 312 281 74 15 19
SIMVASTATIN 312 260 48 15 7
FENTANYL 304 279 36 S2 17 40
METFORMIN HCL 290 252 42 18 15
CARVEDILOL 281 245 40 19 16
ATORVASTATIN CALCIUM 281 178 45 19 14
TRAZODONE HCL 278 190 53 21 20
LORAZEPAM 244 220 67 B 22 22
QUETIAPINE FUMARATE 236 182 29 A 23 30
MORPHINE SULFATE ER 229 170 30 S2 24 79
TAMSULOSIN HCL 229 188 36 24 29
CYMBALTA 207 163 22 26 26
ALPRAZOLAM 199 176 39 B 27 28
ESCITALOPRAM OXALATE 194 189* 24 28 24
HYDROCHLOROTHIAZIDE 192 168 27 29 32
GENERLAC 191 165 18 10 30 143
WARFARIN SODIUM 178 173* 29 31 12
MIRTAZAPINE 177 172* 45 32 17
POLYETHYLENE GLYCOL 3350 175 163 37 33 39
JANUVIA 167 145 14 34 83
DETROL LA 163 123 12 35 113
CLOPIDOGREL 161 156* 26 36 25
CARBIDOPA-LEVODOPA 161 156* 24 36 54
ISOSORBIDE MONONITRATE ER 157 152* 26 38 38
SPIRIVA 151 117 29 39 60
ZOLPIDEM TARTRATE 151 122 28 39 46
GLIPIZIDE 145 133 18 41 42
AGGRENOX 142 142 11 42 95
PANTOPRAZOLE SODIUM 142 113 27 42 36
TRIAMCINOLONE ACETONIDE 136 105 62 44 86
VOLTAREN 135 130* 30 45 88
METOPROLOL SUCCINATE 132 115 18 46 31
DIVALPROEX SODIUM 130 116 23 47 35
BUSPIRONE HCL 129 117 16 48 56
FAMOTIDINE* 129 109 26 48 51
XARELTO 127 115 15 50 120
NOVOLOG 125 104 21 51 44
LOSARTAN POTASSIUM 122 117* 19 52 33
LACTULOSE 119 80 14 53 129
METOCLOPRAMIDE HCL 115 57 20 54 126
LOVASTATIN 114 102 19 55 49
FLUTICASONE PROPIONATE 114 98 48 55 52
CLONIDINE HCL 112 90 26 57 59
ROPINIROLE HCL 110 97 16 58 50
MORPHINE SULFATE 106 56 29 S2 59 104
BUMETANIDE 102 87 14 60 110
FLUOXETINE HCL 101 69 15 61 72
CLOTRIMAZOLE 99 80 40 62 188
TOVIAZ 98 <11 <11 63 190
SPIRONOLACTONE 95 90* 16 64 55
CIPROFLOXACIN HCL 95 83 68 64 74
ADVAIR DISKUS 94 74 21 66 61
AMITIZA 94 <11 <11 66 142
ATENOLOL 93 88* 12 68 37
NEXIUM 90 79 14 69 41
DIOVAN 87 <11 <11 70 48
IPRATROPIUM-ALBUTEROL 85 80* 25 71 53
LEVETIRACETAM 84 53 13 72 58
LIDODERM 84 79* 15 72 65
ZETIA 78 <11 <11 74 115
TEKTURNA 78 <11 <11 74 197
BACLOFEN 78 45 14 74 70
DIVALPROEX SODIUM ER 78 <11 <11 74 89
SERTRALINE HCL 77 60 15 78 21
BENAZEPRIL HCL 77 <11 <11 78 127
TIZANIDINE HCL 77 37 20 78 153
MELOXICAM 75 46 11 81 63
METOLAZONE 75 75 18 81 165
NYSTATIN 74 49 24 83 108
ABILIFY 74 <11 <11 A 83 62
HUMULIN R 74 <11 <11 83 201
NAPROXEN 72 37 23 86 125
PROMETHAZINE HCL 70 46 38 R 87 152
ERYPED 400 69 <11 <11 10 88 204
CRESTOR 69 <11 <11 88 80
PRADAXA 69 <11 <11 88 172
SYMBICORT 68 55 14 91 170
VESICARE 67 62* 14 92 92
PROAIR HFA 67 32 18 92 84
DALIRESP 66 <11 <11 94 208
OXYBUTYNIN CHLORIDE ER 66 <11 <11 94 102
DILTIAZEM HCL 64 <11 <11 96 117
DIGOX 64 <11 <11 96 93
LOVAZA 64 <11 <11 96 145
PAROXETINE HCL 62 <11 <11 99 81
BUPROPION XL 61 <11 <11 100 216
ALENDRONATE SODIUM 58 53* 12 101 57
LATANOPROST 58 53* 12 101 87
EXALGO 57 <11 <11 S2 103 226
NOVOLIN R 57 <11 <11 103 141
ONDANSETRON HCL* 57 57 17 103 114
FINASTERIDE 57 <11 <11 103 82
PRAMIPEXOLE DIHYDROCHLORIDE 56 51* 11 107 132
CYCLOBENZAPRINE HCL 56 <11 13 R 107 108
HALOPERIDOL 56 <11 <11 A 107 121
HYDROMORPHONE HCL* 56 <11 <11 S2 107 228
CARBAMAZEPINE 55 <11 <11 111 181
PREDNISONE 54 49* 23 112 45
CLONAZEPAM 54 34 12 B 112 71
LYRICA 52 <11 <11 114 100
TRAMADOL HCL-ACETAMINOPHEN 52 52 13 114 235
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.